We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA PANEL FINDS GENTA CANCER DRUG INEFFECTIVE
FDA PANEL FINDS GENTA CANCER DRUG INEFFECTIVE
May 7, 2004
An FDA advisory panel last week recommended that the agency reject a new drug application (NDA) for the cancer drug Genasense, saying the clinical trial data submitted in support of the application did not offer substantial evidence of the drug’s efficacy.